Aché is a privately-held company committed to following the best corporate governance practices. We strive to work transparently and ethically as a way of establishing lasting relationships with our publics. We adopt internal policies and processes that go beyond compliance with our legal requirements, and for which we rely on independent auditing for accountability.
The Administrative Council (CA, Conselho de Administração) is formed by four shareholders and six independent directors who are responsible for establishing the guidelines that guide the decisions and the vision of the Company’s future.
The Administrative Council is the body that guides the conduct and governance of the business and considers the positive and negative impacts it generates on society and the environment.
The Council meets periodically to discuss, approve and evaluate strategic planning initiatives and economicfinancial results, and is advised by the Innovation, Digital Transformation, People & ESG, and Finance & Risk Management executive committees.
In 2022, the M&A committee (Mergers and Acquisitions) was created, which has invited external members who are experts in their areas to contribute to the Company’s strategic decisions.
Aché’s Executive Board is responsible for: implementing the strategic plan that is approved by the Administrative Council; ensuring the practice of corporate culture; creating the conditions necessary for sustainable business growth; and complying with the Company’s governance model. To support them in these functions, the Board has eight committees: Internal Audit and Risk Management; Innovation; Market; People & ESG; Strategic Planning; Portfolio and Quality; Financial Results and Digital Transformation and Technology.
Unidades de Negócio
Organizational structure that enables a customized management, developing strategies as per the specificity of each business: Prescription Division, comprising the Prescription and Specialty Care Business Units; Consumer Health Division, comprising the OTC, Generics and Dermatology Business Units, and Biosynthetic Prescription Unit.